| ADP | Adenosine diphosphate |
| BCIS | British Cardiovascular Intervention Society |
| BI | Budget impact |
| BIM | Budget impact model |
| BNF | British National Formulary |
| CVD | Cardiovascular diseases |
| EMA | European Medicines Agency |
| ESC | European Society of Cardiology |
| GPI | Glycoprotein IIb/IIIa receptor inhibitors |
| HES | Hospital episode statistics |
| IDR | Ischemia-driven revascularisation |
| ISPOR | The Profession Society for Health Economics and Outcomes Research |
| IV | Intravenous |
| LOS | Length of stay |
| MI | Myocardial infarction |
| NHS | National Health Service |
| NICE | National Institute of Clinical Excellence |
| OHCA | Out-of-hospital cardiac arrest |
| OWSA | One-way sensitivity analysis |
| PCI | Percutaneous coronary intervention |
| PPCI | Primary percutaneous coronary intervention |
| PSS | Personal Social Services |
| ST | Stent thrombosis |
| STEMI | ST-elevation myocardial infarction |
| TIMI | Thrombolysis in myocardial infarction |